Enzalutamide Price in Philippines,Malaysia

What is the new indication for enzalutamide?

Enzalutamide Price in Philippines, a drug used primarily for prostate cancer, has recently received new indications beyond its traditional use. According to the latest updates:

Non-metastatic castration-resistant prostate cancer (nmCRPC): Enzalutamide has been approved for use in patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease. This indication expands its use to earlier stages of disease progression where the cancer has not yet spread but is resistant to hormonal therapy.

Metastatic castration-sensitive prostate cancer (mCSPC): Enzalutamide is also approved for use in metastatic castration-sensitive prostate cancer. This is a stage where the cancer has spread beyond the prostate but is still responding to hormonal treatments.

These approvals reflect continued advances in prostate cancer treatment, with the goal of extending the benefits of Enzalutamide Price in Malaysia to a broader range of patients. Always consult the latest guidelines or a healthcare provider for the most up-to-date information and personalized treatment options.